New modalities of transdermal testosterone replacement.

Area of Science:

• Endocrinology
• Men's Health
• Pharmacology

Background:

• Hypogonadism negatively affects physiological parameters.
• Intramuscular testosterone esters were historically used but had non-physiologic pharmacokinetics.
• Recent advancements include transdermal testosterone preparations like patches and gels.

Purpose of the Study:

• To evaluate the efficacy and safety of transdermal testosterone replacement therapy.
• To compare transdermal methods with older intramuscular ester formulations.
• To assess the impact of transdermal testosterone on various physiological parameters.

Main Methods:

• Review of studies on transdermal testosterone preparations (scrotal patch, non-scrotal patches, gel).
• Analysis of pharmacokinetic profiles and clinical outcomes.
• Assessment of effects on bone mass, lean body mass, fat mass, mood, and sexual function.

Main Results:

• Transdermal testosterone replacement is physiologic, efficacious, and safe.
• Improvements observed in bone mass, lean body mass, fat mass, mood, and sexual function.
• No adverse effects on prostate or lipids; reduced incidence of acne, polycythemia, and gynecomastia compared to intramuscular esters.

Conclusions:

• Transdermal testosterone therapy is a superior alternative to intramuscular esters for managing hypogonadism.
• This therapy offers significant physiological benefits with an improved safety profile.
• Transdermal testosterone represents a key advancement in treating men with hypogonadism.